MedPath

浙江瑞新药业股份有限公司

Ownership
-
Established
2002-01-08
Employees
-
Market Cap
-
Website
www.zjrxyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

103

NMPA:103

Drug Approvals

Fluorouraciloral Emulsion

Product Name
氟尿嘧啶口服乳
Approval Number
国药准字H33022067
Approval Date
Feb 1, 2024
NMPA

Tetracycline

Product Name
四环素
Approval Number
国药准字H33021588
Approval Date
Feb 1, 2024
NMPA

Vitamin B6

Product Name
维生素B6
Approval Number
国药准字H33020808
Approval Date
Nov 8, 2023
NMPA

Cefuroxime Axetil Capsules

Product Name
头孢呋辛酯胶囊
Approval Number
国药准字H20133100
Approval Date
Nov 14, 2022
NMPA

Mitoxantrone Hydrochloride for Injection

Product Name
注射用盐酸米托蒽醌
Approval Number
国药准字H10960120
Approval Date
Jun 1, 2020
NMPA

Atropine Sulfate Tablets

Product Name
硫酸阿托品片
Approval Number
国药准字H33020464
Approval Date
Jun 1, 2020
NMPA

Polyinosinic-polycytidylic Acid Injection

Product Name
聚肌胞注射液
Approval Number
国药准字H33020859
Approval Date
Jun 1, 2020
NMPA

薄芝菌注射液

Approval Number
国药准字Z20026340
Approval Date
Jun 1, 2020
NMPA

Benproperine Phosphate Capsules

Product Name
磷酸苯丙哌林胶囊
Approval Number
国药准字H33020462
Approval Date
May 29, 2020
NMPA

Pipemidic Acid Capsules

Product Name
吡哌酸胶囊
Approval Number
国药准字H33021275
Approval Date
May 26, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.